135 related articles for article (PubMed ID: 2303130)
41. Protection against myocardial ischaemia by prior haemodilution with fluorocarbon emulsions.
Faithfull NS; Fennema M; Erdmann W
Br J Anaesth; 1988 Jun; 60(7):773-8. PubMed ID: 3395536
[TBL] [Abstract][Full Text] [Related]
42. [Clinical experience of hemodilution with fluosol-DA (author's transl)].
Fukushima K; Nakamura M; Takemura R
Masui; 1981 Jul; 30(7):741-5. PubMed ID: 7321165
[No Abstract] [Full Text] [Related]
43. Improvement in RBC flux, acidosis and oxygenation in tumour microregions by Fluosol-DA 20%.
Lee I; Cunningham WP; Levitt SH
Int J Radiat Biol; 1991 Oct; 60(4):695-705. PubMed ID: 1680148
[TBL] [Abstract][Full Text] [Related]
44. Local oxygen supply of the myocardium after extreme hemodilution with Fluosol-DA.
Kessler M; Vogel H; Günther H; Harrison DK; Höper J
Prog Clin Biol Res; 1983; 122():237-48. PubMed ID: 6878366
[No Abstract] [Full Text] [Related]
45. Failure to determine heparin concentrations in plasma containing Fluosol-DA using an analytical kit.
Shrewsbury RP; White LG
Clin Chim Acta; 1989 Feb; 179(3):347-8. PubMed ID: 2714008
[No Abstract] [Full Text] [Related]
46. Hypotensive reaction after infusion of a perfluorochemical emulsion.
Waxman K; Cheung CK; Mason GR
Crit Care Med; 1984 Jul; 12(7):609-10. PubMed ID: 6610534
[TBL] [Abstract][Full Text] [Related]
47. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
Bajaj AK; Cobb MA; Virmani R; Gay JC; Light RT; Forman MB
Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
[TBL] [Abstract][Full Text] [Related]
48. Changes in plasma enzyme concentrations in response to blood substitution with perfluorocarbon emulsion in the conscious rat.
Lowe KC; McNaughton DC
Experientia; 1986 Dec; 42(11-12):1228-31. PubMed ID: 3780945
[TBL] [Abstract][Full Text] [Related]
49. Increased infection mortality and decreased neutrophil migration due to a component of an artificial blood substitute.
Lane TA; Lamkin GE
Blood; 1986 Aug; 68(2):351-4. PubMed ID: 3524707
[TBL] [Abstract][Full Text] [Related]
50. Effect of Fluosol-DA on radioimmunoassay results.
Hammarstrom M; Mullins R; Sgoutas D
Clin Chem; 1983 Jul; 29(7):1418-21. PubMed ID: 6861348
[TBL] [Abstract][Full Text] [Related]
51. Oxygenated fluorocarbon perfusion as treatment of acute spinal cord compression injury in dogs.
Hansebout RR; van der Jagt RH; Sohal SS; Little JR
J Neurosurg; 1981 Nov; 55(5):725-32. PubMed ID: 7310494
[TBL] [Abstract][Full Text] [Related]
52. Extracorporeal circulation with perfluorochemicals (Fluosol-DA).
Hoshino S; Iwaya F; Igari T; Kanno M; Honda K
J Cardiovasc Surg (Torino); 1982; 23(6):463-9. PubMed ID: 7153234
[TBL] [Abstract][Full Text] [Related]
53. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
Fingar VH; Mang TS; Henderson BW
Cancer Res; 1988 Jun; 48(12):3350-4. PubMed ID: 3130983
[TBL] [Abstract][Full Text] [Related]
54. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
Chaplin DJ; Horsman MR; Aoki DS
Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
[TBL] [Abstract][Full Text] [Related]
55. Cold protected hearts extract oxygen from Fluosol-DA during cardiopulmonary bypass.
Gartman DM; McDonagh PF; Geha AS
Adv Exp Med Biol; 1984; 180():443-50. PubMed ID: 6534118
[No Abstract] [Full Text] [Related]
56. O2 and CO2 solubility of the fluorocarbon emulsion fluosol-DA 20% and O2 and CO2 dissociation curves of blood-fluosol-DA 20% mixtures.
Grote J; Steuer K; Müller R; Söntgerath C; Zimmer K
Adv Exp Med Biol; 1985; 191():453-61. PubMed ID: 3938602
[No Abstract] [Full Text] [Related]
57. Role of the perfluorocarbon Fluosol-DA in coronary angioplasty.
Kerins DM
Am J Med Sci; 1994 Mar; 307(3):218-21. PubMed ID: 8160713
[No Abstract] [Full Text] [Related]
58. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
Teicher BA; Herman TS; Holden SA; Jones SM
J Natl Cancer Inst; 1989 Jun; 81(12):929-34. PubMed ID: 2525198
[TBL] [Abstract][Full Text] [Related]
59. Status of Fluosol-DA 20%.
Carr M
JAMA; 1984 Jun; 251(22):2928. PubMed ID: 6716618
[No Abstract] [Full Text] [Related]
60. Oxygen-transport fluid based on perfluorochemicals: effects on liver biochemistry.
Lowe KC; Armstrong FH
Adv Exp Med Biol; 1990; 277():267-76. PubMed ID: 2096632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
